These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1246006)

  • 41. Morphine as a discriminative stimulus: role of periaqueductal gray neurons.
    Krynock GM; Rosecrans JA
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):49-60. PubMed ID: 441516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Analgesic and narcotic antagonist effects of buprenorphine (author's transl)].
    Hiyama T; Shintani S; Tsutsui M; Yasuda Y
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):147-62. PubMed ID: 7084817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fixed-ratio escape and avoidance-escape from naloxone in morphine-dependent monkeys: effects of naloxone dose and morphine pretreatment.
    Downs DA; Woods JH
    J Exp Anal Behav; 1975 May; 23(3):415-27. PubMed ID: 1170272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic l-alpha acetylmethadol in rhesus monkeys: discriminative stimulus and other behavioral measures of dependence and withdrawal.
    Brandt MR; France CP
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1029-37. PubMed ID: 9864289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of morphine and pentazocine on emotional-behavioral and hemodynamic nociceptive reactions].
    Zaĭtsev AA; Ignatov IuD; Petriaevskaia NV
    Farmakol Toksikol; 1987; 50(1):27-30. PubMed ID: 3556548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time-dependent generalization of morphine stimulus properties to meperidine: antagonism by naloxone.
    Bartoletti M; Gaiardi M; Gubellini C; Bacchi A; Babbini M
    Pharmacol Biochem Behav; 1989 Oct; 34(2):429-31. PubMed ID: 2622998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative cardiac contractile actions of six narcotic analgesics: morphine, meperidine, pentazocine, fentanyl, methadone and l-alpha-acetylmethadol (LAAM).
    Rendig SV; Amsterdam EA; Henderson GL; Mason DT
    J Pharmacol Exp Ther; 1980 Oct; 215(1):259-65. PubMed ID: 6109016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug discrimination analysis of midazolam under a three-lever procedure: I. Dose-dependent differences in generalization and antagonism.
    Sannerud CA; Ator NA
    J Pharmacol Exp Ther; 1995 Jan; 272(1):100-11. PubMed ID: 7815322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Behavioral functions of narcotic antagonists: response-drug contingencies.
    Woods JH; Downs DA; Carney J
    Fed Proc; 1975 Aug; 34(9):1777-84. PubMed ID: 1097266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discriminative stimulus properties of fentanyl and morphine: tolerance and dependence.
    Colpaert FC; Kuyps JJ; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1976 Oct; 5(4):401-8. PubMed ID: 12518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of opiates on the discriminative stimulus properties of dopamine agonists.
    Hernandez LL; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1978 Oct; 9(4):459-63. PubMed ID: 733832
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of the combination of tripelennamine and pentazocine at the behavioral and molecular levels.
    Shannon HE; Su TP
    Pharmacol Biochem Behav; 1982 Oct; 17(4):789-95. PubMed ID: 6294681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The stimulus properties of morphine and ethanol.
    Winter JC
    Psychopharmacologia; 1975 Nov; 44(3):209-14. PubMed ID: 1208757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tripelennamine fails to enhance the morphine-like stimulus effects of pentazocine.
    Oliveto AH; Slifer BL; Dykstra LA
    Pharmacol Biochem Behav; 1988 Feb; 29(2):397-401. PubMed ID: 3362933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.
    Shannon HE; Holtzman SG
    Psychopharmacology (Berl); 1976 Nov; 50(2):119-24. PubMed ID: 826950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of naloxone subcutaneous pellets on relapse to morphine self-administration in post-addict rats.
    Moreton JE; Young GA; Meltzer L; Khazan N
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):209-19. PubMed ID: 1171514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morphine-like stimulus effects in the monkey: opioids with antagonist properties.
    Schaefer GJ; Holtzman SG
    Pharmacol Biochem Behav; 1981 Feb; 14(2):241-5. PubMed ID: 6451874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discriminative stimulus effects of enkephalin analogs, EK-209 and EK-399, in rats.
    Nishida N; Hasegawa Y; Chiba S; Wakimasu M; Fujino M
    Eur J Pharmacol; 1989 Dec; 174(1):71-6. PubMed ID: 2612579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generalization of morphine and lysergic acid diethylamide (LSD) stimulus properties to narcotic analgesics.
    Hirschhorn ID; Rosecrans JA
    Psychopharmacology (Berl); 1976 May; 47(1):65-9. PubMed ID: 8812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discriminative response control by naloxone in morphine pretreated rats.
    Miksic S; Sherman G; Lal H
    Psychopharmacology (Berl); 1981; 72(2):179-84. PubMed ID: 6782608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.